Drug Shortage Report for GLN-URSODIOL
Report ID | 30989 |
Drug Identification Number | 02426919 |
Brand name | URSODIOL TABLETS USP |
Common or Proper name | Ursodiol |
Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | URSODIOL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A05AA |
ATC description | BILE THERAPY |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-11-29 |
Actual start date | 2017-11-29 |
Estimated end date | 2017-12-15 |
Actual end date | 2018-01-01 |
Shortage status | Resolved |
Updated date | 2018-01-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-01-02 | English | Compare |
v5 | 2018-01-01 | French | Compare |
v4 | 2018-01-01 | English | Compare |
v3 | 2017-11-30 | English | Compare |
v2 | 2017-11-28 | French | Compare |
v1 | 2017-11-28 | English | Compare |
Showing 1 to 6 of 6